Drug hypersensitivity reactions: From clinical manifestations to an allergologic diagnosis

European Annals of Allergy and Clinical Immunology

Volumn 37, Issue 6, 2005, Pages 213-218

  Bach, S ^a   Bircher, A J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AMINOPENICILLIN; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BETA LACTAM ANTIBIOTIC; CARBAMAZEPINE; CEFACLOR; CEPHALOSPORIN; CONTRAST MEDIUM; COTRIMOXAZOLE; CYTOSTATIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MINOCYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PHENYLBUTAZONE; PHENYTOIN; PYRAZOLONE DERIVATIVE; QUINIDINE; QUINOLONE DERIVATIVE; RIFAMPICIN; SULFONAMIDE; TETRACYCLINE;

AGRANULOCYTOSIS; ANAPHYLAXIS; ANEMIA; ANGIONEUROTIC EDEMA; ARTICLE; BULLOUS SKIN DISEASE; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; ERYTHEMA MULTIFORME; HEPATITIS; HOSPITALIZATION; HUMAN; IMMUNOLOGY; IN VITRO STUDY; LYMPHADENOPATHY; LYMPHOCYTOSIS; MALAISE; MORTALITY; NEPHRITIS; PNEUMONIA; PROVOCATION TEST; PSEUDOLYMPHOMA; PUSTULE; PUSTULOSIS; RASH; SERUM SICKNESS; SIDE EFFECT; SKIN ALLERGY; SKIN TEST; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VASCULITIS;

ANAPHYLAXIS; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; FEVER; HUMANS; PHARMACEUTICAL PREPARATIONS; SERUM SICKNESS; SKIN TESTS; VASCULITIS;

EID: 22444438454     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Demoly P., Hillaire-Buys D. - Classification and epidemiology of hypersensitivity drug reactions. Immunol Allergy Clin North Am 2004;24(3):345-56, v.
2. Bircher A.-J. - Symptoms and danger signs in acute drug hypersensitivity. Toxicology 2005;209(2):201-7.
3. Roujeau J.-C. - Clinical heterogeneity of drug hypersensitivity. Toxicology 2005;209(2):123-9.
4. Nigen S., Knowles S.-R., Shear N.-H. D- rug eruptions: approaching the diagnosis of drug-induced skin diseases. J Drugs Dermatol 2003;2(3):278-99.
5. Bircher A.-J. - Editorial Arzneimittelallergie. Allergologie 1997;20:367.
6. Lerch M., Pichler W.-J. - The immunological and clinical spectrum of delayed drug-induced exanthems. Curr Opin Allergy Clin Immunol 2004;4(5):411-9.
7. Demoly P., Romano A. - Update on beta-lactam allergy diagnosis. Curr Allergy Asthma Rep 2005;5(1):9-14.
8. Manfredi M., Severino M., Testi S., Macchia D., Ermini G., Fichier W.-J. et al. - Detection of specific IgE to quinolones. J Allergy Clin Immunol 2004;113(1):155-60.
9. Johnson D.-H., Cunha B.-A. - Drug fever. Infect Dis Clin North Am 1996;10:85-91.
10. Wolf R., Orion E., Marcos B., Matz H. - Life-threatening acute adverse cutaneous drug reactions. Clin Dermatol 2005;23(2):171-81.
11. Bocquet H., Bagot M., Roujeau J.-C. - Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cut Med Surg 1996;15:250-7.
12. Prussick R., Knowles S., Shear N.-H. - Cutaneous drug reactions. Curr Probl Dermatol 1994;6(3):85-122.
13. Wolkenstein P., Revuz J. - Drug-induced severe skin reactions. Incidence, management and prevention. Drug Safety 1995;13:56-68.
14. Zeller A., Schaub N., Steffen I., Battegay E., Hirsch H.-H., Bircher A.-J. - Drug hypersensitivity syndrome to carbamazepine and human herpes virus 6 infection: case report and literature review. Infection 2003;31:254-6.
15. Bircher A.-J. - Drug-induced urticaria and angioedema. Eur J Dermatology 1999;9:657-63.
16. Roujeau J.-C., Bioulac-Sage P., Bourseau C., Guillaume J.-C., Bernard P., Lok C. et al. - Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 1991;127:1333-8.
17. Sidoroff A., Halevy S., Bavinck J.-N., Vaillant L., Roujeau J.-C. - Acute generalized exanthematous pustulosis (AGEP)-a clinical reaction pattern. J Cutan Pathol 2001;28(3):113-9.
18. Häusermann P., Harr T., Bircher A.-J. - Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Dermatitis 2004;51:297-310.
19. Lee A.-Y. - Fixed drug eruptions. Incidence, recognition, and avoidance. Am J Clin Dermatol 2000;1(5):277-85.
20. Auquier-Dunant A., Mockenhaupt M., Naldi L., Correia O., Schroder W., Roujeau J.-C. - Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 2002;138(8):1019-24.
21. Doyle M.-K., Cuellar M.-L. - Drug-induced vasculitis. Expert Opin Drug Saf 2003;2(4):401-9.
22. Bircher A.-J. - Arzneimittelallergie. In: Schultze-Werninghaus G, Fuchs T, Bachert C, Wahn U, editors. Manuale allergologicum. München-Deisenhofen: Dustri-Verlag; 2004. p. 677-714.
23. Bircher A.-J. - Arzneimittelallergie und Haut. Stuttgart und New York: Georg Thieme; 1996.
24. Brockow K., Romano A., Blanca M., Ring J., Pichler W., Demoly P. - General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002;57(1):45-51.
25. Barbaud A., Gonçalo M., Bruynzeel D., Bircher A.-J. - Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001;45:321-8.
26. Barbaud A. - Drug patch testing in systemic cutaneous drug allergy. Toxicology 2005;209(2):209-16.
27. Barbaud A. - Approche diagnostique des toxidermies. Rev Fr Allergol 1997;37:370-2.
28. Scherer K., Bircher A.-J. - Hypersensitivity reactions to fluoroquinolones. Curr Allergy Asthma Rep 2005;5(1):15-21.
29. Bircher A.-J., Figueiredo V., Scherer K., Surber C. - Standard operation procedures improve accuracy of serial dilution concentrations for intradermal skin testing. Swiss Med Wkly 2005;135(Suppl. 144):S10.
30. Aberer W., Bircher A., Romano A., Blanca M., Campi P., Fernandez J. et al. - Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003;58(9):854-63.
31. Lebel B., Messaad D., Kvedariene V., Rongier M., Bousquet J., Demoly P. - Cysteinyl-leukotriene release test (CAST) in the diagnosis of immediate drug reactions. Allergy 2001;56(7):688-92.
32. Wedi B., Kapp A. - [Value of the cellular antigen stimulation test (CAST)]. Hautarzt 1997;48(5):347-8.
33. de Weck AL., Sanz M.-L. - Cellular allergen stimulation test (CAST) 2003, a review. J Investig Allergol Clin Immunol 2004;14(4):253-73.
34. Sanz M.-L., Gamboa P., de Weck A.-L. - A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 2005;136(1):58-72.
35. Merk H.-F. - Diagnosis of drug hypersensitivity: lymphocyte transformation test and cytokines. Toxicology 2005;209(2):217-20.
36. Pichler W.-J., Tilch J. - The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004;59(8):809-20.